In a recent health articles it has been described that the hormone medication (Aromatse inhibitors) for the treatment of Breast Cancer has higher risk of Heart Problems.
The drug currently used for breast cancer is tamoxifen.It is mixed antagonist(antagonist of estrogen receptor in tissues of breast.) This drug is now replacing with Aromatse inhibitors.Some commonly used Aromatse inhibitors are:
- Anastrozole
- Letrozole
- Exemestane
- Vorozole
- Formestane
- Fadrozole
The research team tested tamoxifen and 7 Aromatase inhibitors in more than 29,000 patients,They observed that patients treated with Aromatase inhibitors have 25.7% more chances to develop symptoms of heart problems.
"We found that this therapy is closely related to produce more heart problems like angina and heart attacks than the tamoxifen"said by Dr. Eitan Amir.
" Women with post-menopause alongwith breast cancer should take serious precautions with aromatase inhibitors."furtherer said by Dr.Eitan
No comments:
Post a Comment